Our mission is to end children's cancer by driving targeted and innovative research with measurable results in an accelerated time frame.
Improve children's cancer treatment and cures to deliver the potential for childhood cancer patients to lead long, healthy lives.
MESSAGE FROM THE CEO
Recently, Vice President Joe Biden took the lead on a new initiative, the Cancer Moonshot project. The Moonshot is an attempt to martial resources to advance cancer research over the next five years at a rapid rate. On June 29, I attended the Moonshot Summit in Washington DC. The presentations and breakout sessions validated our CureSearch focus to bridge the gap between academia and the pharma industry in order to get new treatments to childhood cancer patients. We know the journey will be one met with challenges, but we must never forget about the overwhelming need for safe, effective treatments for the 15,740 children diagnosed with cancer each year. And, the need is now.
By connecting and collaborating with families, partners, industry experts, and young trailblazers, CureSearch for Children's Cancer is changing the way pediatric cures are discovered and advanced. We recently closed the application period for Acceleration Initiative 3, which will award $2-3M over three years to those dedicated to finding a way to overcome scientific and therapeutic roadblocks. We are also excited to announce the debut of our Catapult Initiative, which will propel discoveries over the Valley of Death and move treatments and cures out of the lab and into clinical trials and eventual commercialization.
All of the initiatives we create have one common goal: save children now. We cannot do this alone, so we will continue to make connections. We will connect with those who are transcending research barriers, and most importantly, with those who are dedicated to finding a cure for every child diagnosed with cancer. Join us. Donate and make a difference in the lives of the 43 children who learned they have cancer today, so that they have a better chance of a future tomorrow.
Until there are cures,
CureSearch for Children's Cancer
CURES WITH INTEGRITY
Ending children's cancer is imperative. At CureSearch, our values guide us in how we are pushing forward to find cures and less-toxic treatments for children with cancer.
HONESTY & INTEGRITY
TRANSPARENCY & ACCOUNTABILITY
CREATIVITY & COLLABORATION
THE CURESEARCH DIFFERENCE
|We focus only on children's cancer.|
|We're not here just to fund research, we're here to drive patient impact.|
|Our Scientific Advisory Council and Scientific Review Board brain trust is unmatched.|
|We invest in large-scale grants over a three-year timeframe, which allows our researchers to focus on their work, not fundraising.|
|We hold ourselves - and our grant recipients - accountable through a novel measurement framework and frequent reporting to our constituents.|
|We build strong, long-term partnerships with our funded researchers so that successful work is supported beyond the scope of their original CureSearch grant.|
|We are bridging the 'valley of death' by creating unique partnerships with biotech and pharma to ensure that promising research makes it out of the lab and into the clinic.|
|We propel discoveries over the Valley of Death and move treatments and cures out of the lab and into clinical trials by bringing together leaders in academia, industry, policy regulation, private foundations, as well as parents to accelerate the fight to end children's cancer.|
By facilitating relationships between academic researchers and the pharmaceutical industry, we can get new cures and treatments out of the lab and to the children.
To facilitate academic-industry partnerships, in 2016 CureSearch formed The Industry Advisory Council (IAC), a team of experts from pharmaceutical companies leading the way in pediatric cancer drug development.
In the complex world of children's cancer research, no independent organization currently coordinates efforts between academic scientists, drug developers, and policy regulators to advance new treatments and cures. Moving forward, CureSearch is proud to play the role of convener and collaborator to bring these key parties together in a way that is singularly focused on accelerating the commercialization of children's cancer treatments to save children now.
Through this ground-breaking initiative, Catapult will propel discoveries over the Valley of Death. We hosted Phase One of the project, The Catapult Summit, on February 28 and 29, 2016 in Menlo Park, California, the home of some of the world's most innovative advancements in medical research. A private and strategically curated event, Catapult Summit participants represent academia, industry, policy regulation, private foundations, and parents. All are leaders in the fight to end children's cancer. Our shared goal - to find solutions that move promising new cancer treatments and cures out of the academic lab and into clinical trials.